LabGenius Appoints Dr. Didier Landais as Chief Operating Officer
22.9.2021 07:00:00 EEST | Business Wire | Press release
LabGenius, the machine learning (ML)-driven protein engineering company, has announced the appointment of Didier Landais Ph.D. as Chief Operating Officer. In this role, Didier will leverage his wealth of experience in business and clinical development to lead the commercialization of LabGenius’ drug discovery platform, EVA TM .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005586/en/
LabGenius Appoints Dr. Didier Landais as Chief Operating Officer (Photo: Business Wire)
“I’m delighted that Didier has joined the team,” said Dr. James Field, Founder and CEO of LabGenius. “Didier is a seasoned operator with 30 years of pharmaceutical industry experience and I’m looking forward to working with him as we rapidly grow the company. It’s a testament to the progress we have made at LabGenius and the exciting opportunities we have ahead of us that we were able to attract someone of Didier’s calibre to join us on our journey.”
Didier joins LabGenius from the pharmaceutical company Servier, where he was The Global Head of Licensing. Under his leadership, Servier signed several notable deals including those with Celsius, Oncodesign and Seal Rock. Prior to Servier, Didier spent over 15 years working for biotechnology and pharmaceutical companies at various stages of development in the US.
Speaking about his appointment, Dr. Didier Landais said: “The team at LabGenius has built an impressive machine learning-driven drug discovery platform with huge potential. I am eager to apply my experience and expertise to support the company’s growth.”
– end –
About LabGenius
LabGenius is a leading ML-driven protein engineering company. The company’s discovery platform, EVATM , integrates several cutting-edge technologies drawn from the fields of computer science, robotic automation and synthetic biology. Headquartered in London, UK, the LabGenius team includes experts in protein engineering, synthetic biology, software engineering, data science and robotic automation.
For more information, please visit www.labgeni.us, or connect on Twitter, Facebook, and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005586/en/
Contact information
Media enquiries:
Communications Lead
Lucy Shaw
press@labgeni.us
Business development:
Chief Operating Officer
Didier Landais
didier.landais@labgeni.us
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mouser Explores the Future of Quantum Computing and Its Potential to Transform Engineering11.8.2026 17:48:00 EEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today announced the latest installment of its Empowering Innovation Together (EIT) technology series, A Quantum Leap in Computer Processing. This installment explores the emerging field of quantum computing and examines how the principles of quantum mechanics could unlock new computational capabilities for solving problems that remain difficult for conventional computing architectures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260811222432/en/ Explore how quantum computing could help engineers address problems too complex for traditional systems. Unlike traditional computers, quantum computers leverage quantum-mechanical phenomena, such as superposition, entanglement, and interference, to perform calculations in fundamentally different ways. While today's quantum systems still face challe
Andersen Global Expands Legal Capabilities with Beech Incorporated11.8.2026 16:30:00 EEST | Press release
Andersen Global enters into a Collaboration Agreement with Beech Incorporated, a legal firm based in South Africa, broadening its legal capabilities in the region. Beech Incorporated provides legal and regulatory services to the mining, renewable energy, infrastructure, oil and gas sectors, specializing in mergers and acquisitions, commercial, project financing, health, safety and environmental, employment, and compliance matters. The firm’s multidisciplinary team advises clients across the full project lifecycle—from development and financing to operations and stakeholder engagement—and is recognized as a leading legal firm by publications including Chambers and Partners and The Legal 500. “Our approach is built on understanding the industries we serve at a practical level and providing practical, actionable advice to clients operating in complex regulatory environments,” said Warren Beech, CEO of Beech Incorporated. “By working alongside the member and collaborating firms of Andersen
Rehlko Expands Power Plus™ Connected-Services Capabilities, Enhancing Value Across Installed Base11.8.2026 16:15:00 EEST | Press release
Rehlko, a global industrial energy resilience platform providing custom-engineered, integrated power solutions for mission-critical infrastructure worldwide, today announced the expanded capabilities of Rehlko Power Plus™ industrial remote monitoring. The cloud-based platform is designed to help customers reduce downtime, improve backup power reliability, and proactively manage critical power assets through real-time monitoring, alerts, diagnostics, and reporting. Rehlko Power Plus represents a meaningful expansion of Rehlko’s aftermarket capabilities and reinforces the company's strategy to deepen customer engagement across the asset lifecycle while growing its higher-value aftermarket business. As backup power systems become increasingly critical to business continuity, organizations need more than periodic inspections and reactive maintenance. Rehlko Power Plusenables customers and distributors to continuously monitor generators and automatic transfer switches, receive real-time ale
Boomi Ranked #1 Overall Leader in the 2026 ISG Buyers Guide™ for Application Integration11.8.2026 16:00:00 EEST | Press release
Boomi, the data activation company for AI, today announced it has been ranked the #1 overall software provider in ISG Buyers Guides™ for Application Integration 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260811102868/en/ Boomi Ranked #1 Overall Leader in the 2026 ISG Buyers Guide™ for Application Integration In the report published by ISG Software Research, a division of ISG (Information Services Group), Boomi was placed within ISG's highest quadrant classification, Exemplary. ISG's report states that “Boomi was designated a Leader Overall and in every category,” a distinction no other provider assessed achieved. Capability, Platform and Customer Experience Leader The ISG Buyers Guide™ looks at how well software providers deliver for their customers, evaluating both the product itself and the overall experience of working with the company. Boomi came out on top, earning the #1 Overall ranking and #1 in Capability a
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer11.8.2026 15:30:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the appointments of Jim Wassil, currently Chief Operating Officer at Vaxcyte; Suha Jhaveri, former Strategic Advisor at Cidara before its acquisition by Merck; and Bill Warren, former Global Head of Antigen Design at Sanofi Vaccines, as independent members of ILiAD’s Board of Directors. The Company also announced the appointment of Antony Blanc, former VP, Head of Global Marketing and Global Strategic Pricing at GSK Vaccines, as Chief Business Officer. “Our recently appointed colleagues bring an extraordinary depth of experience in vaccine development, global commercialization, and strategic growth,” said Keith Rubin, MD, Founder and Chief Executive Officer of ILiAD. “As we advance BPZE1 to the next pivotal phase of ILiAD’s growth, the insights and leadership of Antony, Bill, Jim and Suha will be invaluable in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom